200 related articles for article (PubMed ID: 8438156)
1. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
[TBL] [Abstract][Full Text] [Related]
2. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.
Nagarajan L; Zavadil J; Claxton D; Lu X; Fairman J; Warrington JA; Wasmuth JJ; Chinault AC; Sever CE; Slovak ML
Blood; 1994 Jan; 83(1):199-208. PubMed ID: 8274735
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
[TBL] [Abstract][Full Text] [Related]
4. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
Boultwood J; Fidler C; Lewis S; MacCarthy A; Sheridan H; Kelly S; Oscier D; Buckle VJ; Wainscoat JS
Blood; 1993 Nov; 82(9):2611-6. PubMed ID: 8219215
[TBL] [Abstract][Full Text] [Related]
5. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31).
Green WB; Slovak ML; Chen IM; Pallavicini M; Hecht JL; Willman CL
Leukemia; 1999 Dec; 13(12):1960-71. PubMed ID: 10602416
[TBL] [Abstract][Full Text] [Related]
6. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
7. Deletions of chromosome 5 in malignant myeloid disorders.
Le Beau MM
Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
[TBL] [Abstract][Full Text] [Related]
8. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.
Harada H; Kondo T; Ogawa S; Tamura T; Kitagawa M; Tanaka N; Lamphier MS; Hirai H; Taniguchi T
Oncogene; 1994 Nov; 9(11):3313-20. PubMed ID: 7936656
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene.
Dubourg C; Toutain B; Hélias C; Henry C; Lessard M; Le Gall JY; Le Treut A; Guenet L
Cancer Genet Cytogenet; 2002 Apr; 134(1):33-7. PubMed ID: 11996793
[TBL] [Abstract][Full Text] [Related]
10. Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor.
Hejlik DP; Kottickal LV; Liang H; Fairman J; Davis T; Janecki T; Sexton D; Perry W; Tavtigian SV; Teng DH; Nagarajan L
Cancer Res; 1997 Sep; 57(17):3779-83. PubMed ID: 9288787
[TBL] [Abstract][Full Text] [Related]
11. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.
Horrigan SK; Arbieva ZH; Xie HY; Kravarusic J; Fulton NC; Naik H; Le TT; Westbrook CA
Blood; 2000 Apr; 95(7):2372-7. PubMed ID: 10733509
[TBL] [Abstract][Full Text] [Related]
12. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer.
Nozawa H; Oda E; Ueda S; Tamura G; Maesawa C; Muto T; Taniguchi T; Tanaka N
Int J Cancer; 1998 Aug; 77(4):522-7. PubMed ID: 9679752
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
14. Identification of NKIAMRE, the human homologue to the mitogen-activated protein kinase-/cyclin-dependent kinase-related protein kinase NKIATRE, and its loss in leukemic blasts with chromosome arm 5q deletion.
Midmer M; Haq R; Squire JA; Zanke BW
Cancer Res; 1999 Aug; 59(16):4069-74. PubMed ID: 10463609
[TBL] [Abstract][Full Text] [Related]
15. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60.
Zavadil J; Brezinová J; Svoboda P; Zemanová Z; Michalová K
Leukemia; 1997 Aug; 11(8):1187-92. PubMed ID: 9264367
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
17. Localization of the human chromosome 5q genes Gabra-1, Gabrg-2, Il-4, Il-5, and Irf-1 on mouse chromosome 11.
Buckwalter MS; Lossie AC; Scarlett LM; Camper SA
Mamm Genome; 1992; 3(10):604-7. PubMed ID: 1358285
[No Abstract] [Full Text] [Related]
18. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.
Beretta L; Gabbay M; Berger R; Hanash SM; Sonenberg N
Oncogene; 1996 Apr; 12(7):1593-6. PubMed ID: 8622878
[TBL] [Abstract][Full Text] [Related]
19. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
20. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]